News & Articles

Access Anti-SARS-CoV-2 Antigen Test, developed in collaboration with Ellume, aims to provide accurate results in less than 15 minutes

Agreements with AstraZeneca and the University of Nebraska Medical Center showcase new workflows to improve the throughput, robustness and standardization of clinical biomarker analysis

RiboShield RNase Inhibitor complements PCR Biosystems’s range of products to support COVID-19 research and testing

The agreement is part of preparations for GMP production of material for the first clinical study of CG01

Leinco Technologies has launched the COVID-19 ImmunoRank Neutralization ELISA Test Kit

Watch this on-demand webinar to discover the critical factors when choosing an assay for coronavirus testing

Join us on Monday, September 21, to learn about assay development for high-throughput screening

New research published in Nature Immunology show strong T cell responses in patients recovered from COVID-19

CDx approval expands clinical utility of Oncomine Dx Target Test to identify candidates for GAVRETO

New test expands Roche molecular test menu for transplant patients, enabling simultaneous testing of BK virus with Cytomegalovirus and Epstein-Barr virus

Test to be integrated in over 5,000 DiaSorin analyzers, allowing physicians to differentiate between bacterial and viral infections

Sanofi and GSK are scaling up the manufacturing of the antigen and adjuvant with the target of producing up to one billion doses in 2021

Following successful evaluation by The Liverpool School of Tropical Medicine, the ELISA test will now be made available for COVID-19 researchers

Read this application note to discover how T cell activation assays can help accelerate COVID-19 vaccine development

Data shows 100% concordance with results from Dartmouth-Hitchcock’s lab-based polymerase chain reaction (PCR) test method

Rapid increase in production of VTM and saline will help boost virus testing

A new prognostic tool developed by an international team led by CTI-Bath paves the way for personalized medicine for cancer patients

Watch this on-demand webinar to learn about the latest approaches in single nucleus transcriptomics and ATAC-Seq

The new AI technology will learn from past CT scans of COVID-19 pneumonia patients, reducing the burden on doctors making diagnoses

Ready-to-use kit enables rapid adeno-associated virus (AAV) titer determinations during the manufacture of AAV vectors

Antigen test reliably and quickly triages people suspected of SARS-CoV-2, with results ready in 15 minutes, allowing informed treatment decisions